Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Transdermal patches estradiol

Switching from an oral contraceptive - Treatment with the norelgestromin/ethinyl estradiol transdermal patch should begin on the first day... [Pg.208]

Use after childbirth - Women who elect not to breast-feed should start contraceptive therapy with the norelgestromin/ethinyl estradiol transdermal patch no sooner than 4 weeks after childbirth. If a woman begins using the patch postpartum and has not yet had a period, consider the possibility of ovulation and conception occurring prior to use of the patch, and instruct her to use an additional method of contraception (eg, condoms, spermicide, diaphragm) for the first 7 days. [Pg.209]

Patch - Results of clinical trials suggest that the norelgestromin/ethinyl estradiol transdermal patch may be less effective in women with body weight 90 kg or more (198 lbs) than in women with lower body weights. [Pg.219]

FIGURE 52-1. This low-dose estrogen transdermal patch, available as the trade name Estraderm (Estradiol Transdermal System), is transparent and about the size of a silver dollar. It releases small amounts of estrogen directly into the bloodstream at a constant and controlled rate to a female requiring estrogen replacement therapy for postmenopausal symptoms. [Pg.557]

Ortho-Evra is a transdermal patch that contains both an estrogen (20 meg of ethinyl estradiol) and a progestin (150 meg... [Pg.746]

Other than possibly for the insensible perspiration they absorb, transdermal patches tend to operate as thermodynamically static systems, meaning as com-positionally fixed systems, from the moment they are applied until their removal. Marketed ethanol-driven estradiol and fentanyl patches are exceptions because they meter out ethanol and drive it into the stratum corneum to propel the absorption process. Compositional steadfastness is still the rule, however, and it is this feature that bestows the zero-order delivery attribute on the ordinary transdermal patch. Drug is present within the patches in reservoir amounts whether or not the reservoir compartment is easily distinguished, for there must be enough drug to sustain delivery over the full course of patch wear. [Pg.232]

Transdermal 17/3-estradiol 50 meg 25 meg Transdermal (patch) Once or twice weekly... [Pg.357]

Transdermal patch 0.045 mg estradiol/0.015 mg levonorgestrel per day (Rx) ClimaraPro (Berlex)... [Pg.185]

A 47-year-old postmenopausal woman developed eczematous lesions at the sites of application of an estradiol transdermal system and subsequently at the sites of application of an estradiol gel (55). She was therefore given oral estrogen instead, but this promptly elicited a systemic pruritic rash. The causal link was in all instances confirmed by patch-testing. [Pg.177]

Rovati LC, Setnikar I, Genazzani AR. Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group. Gynecol Endocrinol 2000 14(4) 282-91. [Pg.199]

De Aloysio D, Rovati LC, Giacovelli G, Setnikar I, Bottiglioni F. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study. Arzneimittelforschung 2000 50(3) 293-300. [Pg.200]

Nonoral contraceptives Ethinyl estradiol Norelgestromin Ortho Evra (transdermal patch)... [Pg.451]

Figure 1.8 Schematic of transdermal patch in which the rate of delivery of drug to the body is controlled by a polymer membrane. Such patches are used to deliver many drugs including nitroglycerine, estradiol, nicotine and scopalamine... Figure 1.8 Schematic of transdermal patch in which the rate of delivery of drug to the body is controlled by a polymer membrane. Such patches are used to deliver many drugs including nitroglycerine, estradiol, nicotine and scopalamine...
Transdermal patches are marketed worldwide with the drug substances glycerole trinitrate, estradiol, testosterone, clonidine, scopolamine, fentanyl and nicotine, respectively. The patch has to remain for up to one week at the appropiate body site. In this case the drug amount in the reservoir is rather high. As liquid crystalline vehicles with lamellar microstructure have... [Pg.1129]

Transdermal Contraceptives. In 2001. the FDrug Administration (FDA) approved the first transdermal contraceptive patch. Onho-Evra. The product contains norel-gestnrmin and ethinyl estradiol. A patch is applied once a week for. 1 weeks, followed by a week with no patch. The pregnancy rate for this product is I in 100. a rale similar to that often observed with oral eonlraceplives. [Pg.794]

Estradiol 25-200 meg transdermal patch (once-weekly patch or twice-weekly patch replacement) vaginal cream,... [Pg.1472]

Estradiol 100-200 meg transdermal patch every 3-7 days with add-back progesterone... [Pg.1472]

ESTRADIOL/LEVONORGESTREL (ClimaraPro transdermal patch estradiol 0.045 mg and levonorgestrel 0.015 mg per day)... [Pg.247]

ESTRADIOL/NORETHINDRONE ACETATE (CombiPatch transdermal patch 0.05 mg estradiol/... [Pg.248]

See other pages where Transdermal patches estradiol is mentioned: [Pg.89]    [Pg.391]    [Pg.545]    [Pg.208]    [Pg.142]    [Pg.155]    [Pg.710]    [Pg.924]    [Pg.155]    [Pg.450]    [Pg.976]    [Pg.473]    [Pg.171]    [Pg.45]    [Pg.194]    [Pg.275]    [Pg.847]    [Pg.391]    [Pg.3823]    [Pg.3846]    [Pg.1697]    [Pg.1476]    [Pg.1477]    [Pg.155]    [Pg.248]   
See also in sourсe #XX -- [ Pg.277 ]



SEARCH



Estradiol

Patches

Transdermal

Transdermal patch

© 2024 chempedia.info